Ultimately, these studies highlight the relevance of the HO-1/CO pathway in monocytes/MΦs as a therapeutic target in controlling neutrophilic lung inflammation in pathological conditions such as CF. The gene discussed is HMOX1; the disease is cystic fibrosis.